Advanced Solid Tumors: INCB123667 Study

We are testing a new drug, INCB123667, alone and with other cancer therapies for people with advanced solid tumors. The goal is to understand its effects and potential benefits in treating these cancers.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Medical Oncology
Bordeaux, France
Centre Leon Berard
Medical Oncology
Meyzieu, France
Institut Universitaire Du Cancer Toulouse-Oncopole
Medical Oncology
Portet-sur-Garonne, France

Sponsor: Incyte Corp.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.